Filing Details

Accession Number:
0001104659-25-012364
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-12 19:59:41
Reporting Period:
2025-02-10
Filing Date:
2025-02-12
Accepted Time:
2025-02-12 19:59:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773427 Springworks Therapeutics Inc. SWTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1177082 Daniel Lynch C/O Springworks Therapeutics, Inc.
100 Washington Blvd.
Stamford CT 06902
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-10 69,766 $53.23 236,178 No 4 S Direct
Common Stock Disposition 2025-02-10 39,634 $54.88 196,544 No 4 S Direct
Common Stock Disposition 2025-02-10 65,600 $55.51 130,944 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on May 3, 2024.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $55.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.40 to $55.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.